Also trades as: PHASQ (OTC) · $vol 0M
PHAS NASDAQ
PhaseBio Pharmaceuticals, Inc.
1W: -42.4%
1M: -62.8%
3M: -94.3%
1Y: -98.3%
3Y: -98.4%
$0.07
Last traded 2022-11-02 — delisted
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
📊 Key Metrics
TTM$1M
Revenue
-92.3% YoY
$28M
Net Income
+125.0% YoY
$-62M
Free Cash Flow
-26.0% YoY
100.0%
Gross Margin
-7956.2%
Op. Margin
-8067.8%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE-40.8%
ROA45.3%
ROIC-25.7%
Valuation
P/E-15.6
P/B-0.0
EV/EBITDA1.0
Leverage
Debt/Equity-0.05
Current Ratio0.47
Interest Cov.21.0x
Quality Scores
Piotroski F2/9
Altman Z-23.14
Beneish M4.89